[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335176-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-335176-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","somatic-mutations-in-tumor-infiltrating-lymphocytes-impact-on-antitumor-immunity","Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity","","Immune checkpoint inhibitors can restore exhausted CD8+ T cells within tumor-infiltrating lymphocytes (TILs), but how somatic mutations in TILs shape antitumor immunity remains unclear. This study generated 18 exhaustion-phenotype, cancer-specific T cell clones from four melanoma patients and performed whole-genome sequencing to reveal high-clonality somatic mutations. An SH2D2A loss-of-function frameshift and TNFAIP3 deletion activated T cell effector functions in vitro, while CD8+ Tnfaip3 knockout mice showed increased antitumor immunity and improved PD-1 blockade responses. Bulk CD3+ T cells from 12 additional patients identified an SH2D2A mutation in one patient, supporting TIL-mutation-based biomarkers and therapeutic targets.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/somatic-mutations-in-tumor-infiltrating-lymphocytes-impact-on-antitumor-immunity/335176/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/somatic-mutations-in-tumor-infiltrating-lymphocytes-impact-on-antitumor-immunity/335176.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about tumor-infiltrating lymphocytes (TILs)?","Question",{"text":63,"@type":64},"The study investigates whether somatic mutations present in TILs can influence antitumor immunity and help explain why immune checkpoint therapy responses vary.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were somatic mutations in TIL-derived cancer-specific T cells identified?",{"text":68,"@type":64},"Researchers established 18 cancer-specific T cell clones from melanoma TILs and performed whole-genome sequencing to detect various somatic mutations with high clonality. They also used amplicon sequencing on bulk CD3+ T cells from additional patients.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genetic alterations were linked to enhanced T cell effector functions?",{"text":72,"@type":64},"An SH2D2A loss-of-function frameshift mutation and TNFAIP3 deletion were shown to activate T cell effector functions in vitro.",{"name":74,"@type":61,"acceptedAnswer":75},"What did the Tnfaip3 knockout mouse experiments show for immunotherapy outcomes?",{"text":76,"@type":64},"CD8+ T cell–specific Tnfaip3 knockout increased antitumor immunity and produced a remarkable response to PD-1 blockade in vivo.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},335176,1790174515,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \nMEDICAL SCIENCES  \nSomatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity  \nFumiaki Mukoharaa, b,1, Kazuma Iwataa, b,1, Takamasa Ishinoa,c,2, Takashi Inozumed,e,f, Joji Nagasakia, Youki Uedaa , Ken Suzawab, Toshihide Uenog , Hideki Ikedae, h , Katsushige Kawasee, i, Yuka Saekid , Shusuke Kawashimad,e , Kazuo Yamashitaj, Yu Kawaharad, k, Yasuhiro Nakamurak ,  \nAkiko Honobe-Tabuchif, Hiroko Watanabea , Hiromichi Dansakoa , Tatsuyoshi Kawamuraf, Yutaka Suzukil , Hiroaki Hondam , Hiroyuki Manog,  \nShinichi Toyookab, Masahito Kawazue,g,2, and Yosuke Togashia,e, n,2 Affiliations are included on p. 10.  \nEdited by Rafi Ahmed, Emory University School of Medicine, Atlanta, GA; received December 1, 2023; accepted July 5, 2024  \nImmune checkpoint inhibitors (ICIs) exert clinical efficacy against various types of cancers by reinvigorating exhausted CD8+ T cells that can expand and directly attack cancer cells (cancer-specific T cells) among tumor-infiltrating lymphocytes (TILs) . Although some reports have identified somatic mutations in TILs, their effect on antitumor immunity remains unclear. In this study, we successfully established 18 cancer-specific T cell clones, which have an exhaustion phenotype, from the TILs of four patients with melanoma. We conducted whole-genome sequencing for these T cell clones and identified various somatic mutations in them with high clonality. Among the somatic mutations, an SH2D2A loss-of-function frameshift mutation and TNFAIP3 deletion could activate T cell effector functions in vitro. Furthermore, we generated CD8+ T cell–specific Tnfaip3 knockout mice and showed that Tnfaip3 function loss in CD8+ T cell increased antitumor immunity, leading to remarkable response to PD-1 blockade in vivo. In addition, we analyzed bulk CD3+ T cells from TILs in additional 12 patients and identified an SH2D2A mutation in one patient through amplicon sequencing. These findings suggest that somatic mutations in TILs can affect antitumor immunity and suggest unique biomarkers and therapeutic targets.  \ncancer immunology | somatic mutation | T cell | tumor-infiltrating lymphocytes  \nCancer immunotherapies, especially immune checkpoint inhibitors (ICIs), exhibit efficacy by reinvigorating effector CD8+ T cells among tumor-infiltrating lymphocytes (TILs) and have been approved for multiple types of cancer (1–4). Although a durable response and favorable clinical prognosis have been reported in some patients, a low response rate, severe immune-related adverse events, and acquired resistance limit the use of ICIs (1–4) . Therefore, further understanding of antitumor immune responses is urgently needed to identify predictive biomarkers and more effective immunotherapies. Among the effector CD8+ T cells in TILs, the T cells that directly attack cancer cells (cancer-specific T cells) are the most important (5). Therefore, such cancer-specific T cells appear to be key clues for understanding antitumor immune responses in detail.  \nNormal tissues obtain somatic mutations that lead to clonal expansion and carcinogenesis (6, 7), and hematological cells gain somatic mutations. Some somatic mutations in hematological cells, particularly in leukemia-associated genes, can lead to the clonal expansion of hematopoietic stem cells without malignant transformation, which is termed clonal hematopoiesis of indeterminate potential (CHIP) . CHIP is associated with an increased risk of hematological malignancy, cardiovascular disease, and all-cause mortality owing to increased inflammation (8–12) . Furthermore, there is increasing evidence that patients with solid malignancies have higher rates of CHIP than the general population and that CHIP affects the outcomes of patients with solid malignancies (13–17). A recent study also revealed an association between CHIP and differential outcomes by ICIs (18) . In addition, recent studies have identified somatic mutations in TILs (19–21). Although somatic m","cbCaiiL2d0JjJAPx","https://ap.wps.com/l/cbCaiiL2d0JjJAPx","pdf",7932462,11,"English","# Introduction\n## Rationale and clinical need for biomarkers\n# Methods\n## Whole-genome sequencing of cancer-specific T cell clones\n## In vitro functional assays and in vivo mouse models\n# Results\n## Somatic mutations and activation of T cell effector functions\n## Tnfaip3 loss enhances antitumor immunity and PD-1 blockade response\n## Additional patient validation via sequencing\n# Significance\n## Implications for biomarkers and therapeutic targets","[{\"question\":\"What question does the study address about tumor-infiltrating lymphocytes (TILs)?\",\"answer\":\"The study investigates whether somatic mutations present in TILs can influence antitumor immunity and help explain why immune checkpoint therapy responses vary.\"},{\"question\":\"How were somatic mutations in TIL-derived cancer-specific T cells identified?\",\"answer\":\"Researchers established 18 cancer-specific T cell clones from melanoma TILs and performed whole-genome sequencing to detect various somatic mutations with high clonality. They also used amplicon sequencing on bulk CD3+ T cells from additional patients.\"},{\"question\":\"Which genetic alterations were linked to enhanced T cell effector functions?\",\"answer\":\"An SH2D2A loss-of-function frameshift mutation and TNFAIP3 deletion were shown to activate T cell effector functions in vitro.\"},{\"question\":\"What did the Tnfaip3 knockout mouse experiments show for immunotherapy outcomes?\",\"answer\":\"CD8+ T cell–specific Tnfaip3 knockout increased antitumor immunity and produced a remarkable response to PD-1 blockade in vivo.\"}]","Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity | PDF",1790009948,28]